|
1 Company |
|
3 Products |
|
3 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
14 News |
|
- | methylprednisolone oral / Generic mfg.
Trial completion, Enrollment change: The Efficacy of Steroid Therapy in Vestibular Neuritis (clinicaltrials.gov) - Jan 11, 2019
P3, N=40, Completed, Sponsor: Asan Medical Center
Active, not recruiting --> Completed | N=60 --> 40
- cilostazol / Generic mfg.
Enrollment change, Trial termination: Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy (clinicaltrials.gov) - Feb 18, 2016
P3, N=26, Terminated, Sponsor: Jong Woo Chung
N=72 --> 26 | Recruiting --> Terminated; Participant enrollment is much delayed. The whole design needs to be revised.
- ||| Trial completion, Enrollment change, Trial primary completion date: Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool (clinicaltrials.gov) - Feb 9, 2016
P=N/A, N=126, Completed, Sponsor: Emory University
The whole design needs to be revised. Recruiting --> Completed | N=100 --> 126 | Trial primary completion date: Dec 2015 --> Sep 2015
- || Trial primary completion date: Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=100, Recruiting, Sponsor: Emory University
Recruiting --> Completed | N=100 --> 126 | Trial primary completion date: Dec 2015 --> Sep 2015 Trial primary completion date: Aug 2015 --> Dec 2015
- ||| Enrollment open: Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool (clinicaltrials.gov) - May 13, 2015
P=N/A, N=100, Recruiting, Sponsor: Emory University
Trial primary completion date: Aug 2015 --> Dec 2015 Not yet recruiting --> Recruiting
- | methylprednisolone oral / Generic mfg.
Clinical: The Efficacy of Steroid Therapy in Vestibular Neuritis (clinicaltrials.gov) - Jan 28, 2015
P3, N=60, Active, not recruiting, Sponsor: Asan Medical Center
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- |||| cilostazol / Generic mfg.
Trial primary completion date: Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy (clinicaltrials.gov) - Jan 15, 2015
P3, N=72, Recruiting, Sponsor: Jong Woo Chung
Recruiting --> Active, not recruiting Trial primary completion date: May 2014 --> Dec 2015
- || Enrollment change, Trial initiation date, Trial primary completion date: Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool (clinicaltrials.gov) - Oct 31, 2014
P=N/A, N=100, Not yet recruiting, Sponsor: Emory University
Trial primary completion date: May 2014 --> Dec 2015 N=76 --> 100 | Initiation date: Jul 2014 --> Dec 2014 | Trial primary completion date: Jan 2015 --> Aug 2015
- Enrollment change: Recovery of Visual Acuity in People With Vestibular Deficits (clinicaltrials.gov) - Jul 21, 2014
P=N/A, N=23, Completed, Sponsor: Emory University
N=76 --> 100 | Initiation date: Jul 2014 --> Dec 2014 | Trial primary completion date: Jan 2015 --> Aug 2015 N=98 --> 23
- Clinical: Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=76, Not yet recruiting, Sponsor: Emory University
- || methylprednisolone oral / Generic mfg.
Clinical: The Efficacy of Steroid Therapy in Vestibular Neuritis (clinicaltrials.gov) - Mar 26, 2014
P3, N=60, Recruiting, Sponsor: Asan Medical Center
- | cilostazol / Generic mfg.
Enrollment open: Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy (clinicaltrials.gov) - Sep 24, 2013
P3, N=72, Recruiting, Sponsor: Jong Woo Chung
N=98 --> 23 Not yet recruiting --> Recruiting
- || cilostazol / Generic mfg.
New P3 trial: Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy (clinicaltrials.gov) - Jul 4, 2013
P3, N=72, Recruiting, Sponsor: Jong Woo Chung
- Trial completion: Recovery of Visual Acuity in People With Vestibular Deficits (clinicaltrials.gov) - Jun 11, 2012
P=N/A, N=98, Completed, Sponsor: Emory University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed